Global Pharmacovigilance Outsourcing Market
Global Pharmacovigilance Outsourcing Market

Pharmacovigilance Outsourcing Comprehensive Study by Services (Pre-marketing Pharmacovigilance Services (Clinical Pharmacovigilance Services, Case-Processing Services, Safety Data Management Services, Medical Review) Post-marketing Pharmacovigilance Services (Pharmacovigilance Knowledge Process Outsourcing Services, IT Solutions, and Services)), Service Providers (Contract Research Organizations, Business Processing Outsourcing), Clinical Trial Phase (Pre-Clinical, Phase I, Phase II, Phase III, Phase IV) Players and Region - Global Market Outlook to 2025

Pharmacovigilance Outsourcing Market Segmented into XX Submarkets. | Forecast Years: 2020- 2025  

Mar 2020 Edition 212 Pages 212 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Pharmacovigilance Outsourcing Market Scope
A pharmacovigilance outsourcing enables the clients to interact with one service provider for all the Pharmacovigilance (PV) and regulatory requirements, which translates into a cost and time-effective strategy. Pharmacovigilance outsourcing (PVO) transfers the execution of drug safety functions and processes to a third-party provider. These include primary PV activities like case processing, as well as governance activities like compliance management. These services are majorly outsourced by small and mid-size pharmaceutical and biotechnology companies with an aim to save costs and focus on the companyís core activities.

The market study is being classified and major geographies with country level break-up.

Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Pharmacovigilance Outsourcing market throughout the predicted period.

Accenture plc (Ireland), Clinquest Group B.V (Netherlands), Cognizant (United States), Laboratory Corporation of America Holdings (United States), IBM (United States), ArisGlobal LLC (United States), ITClinical (Portugal), Foresight Group International AG (Switzerland), Take Solutions Ltd. (India) and Parexel International (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Bioclinica (United States).

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Pharmacovigilance Outsourcing market by Type, Application and Region.

On the basis of geography, the market of Pharmacovigilance Outsourcing has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Market Leaders and their expansionary development strategies
In April 2018, HCL Technologies announced the acquisition of C3i Solutions, a leading service provider for life sciences and consumer packaged goods industries. The acquisition aimed at using C3iís expertise in the clinical, pharmacovigilance domain to accelerate the Indian IT firm's growth in life sciences.



Market Trend
  • Increasing the Emphasis of Players in the Healthcare Sector Regarding the Treatment of Disease

Market Drivers
  • Cost-effective Pharmacovigilance Services in Developing Countries
  • High Profile Drug Recalls due to Safety Concerns

Opportunities
  • High Potential in Developing Countries
  • Increasing Adverse Drug Reactions Associated with Pharmaceutical Products Used in the Prevention and Treatment of Various Diseases

Restraints
  • The Risk associated with Data Security

Challenges
  • The Dearth of Skilled Personnel


Key Target Audience
Pharmacovigilance Outsourcing Providers, Potential Investors, Research and Development Firm and End-User Industries

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Services
  • Pre-marketing Pharmacovigilance Services (Clinical Pharmacovigilance Services, Case-Processing Services, Safety Data Management Services, Medical Review) Post-marketing Pharmacovigilance Services (Pharmacovigilance Knowledge Process Outsourcing Services, IT Solutions, and Services)

By Service Providers
  • Contract Research Organizations
  • Business Processing Outsourcing

By Clinical Trial Phase
  • Pre-Clinical
  • Phase I
  • Phase II
  • Phase III
  • Phase IV

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Cost-effective Pharmacovigilance Services in Developing Countries
      • 3.2.2. High Profile Drug Recalls due to Safety Concerns
    • 3.3. Market Challenges
      • 3.3.1. The Dearth of Skilled Personnel
    • 3.4. Market Trends
      • 3.4.1. Increasing the Emphasis of Players in the Healthcare Sector Regarding the Treatment of Disease
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Pharmacovigilance Outsourcing, by Services, Service Providers , Clinical Trial Phase and Region (value and price ) (2014-2019)
    • 5.1. Introduction
    • 5.2. Global Pharmacovigilance Outsourcing (Value)
      • 5.2.1. Global Pharmacovigilance Outsourcing by: Services (Value)
        • 5.2.1.1. Pre-marketing Pharmacovigilance Services (Clinical Pharmacovigilance Services, Case-Processing Services, Safety Data Management Services, Medical Review) Post-marketing Pharmacovigilance Services (Pharmacovigilance Knowledge Process Outsourcing Services, IT Solutions, and Services)
      • 5.2.2. Global Pharmacovigilance Outsourcing by: Clinical Trial Phase (Value)
        • 5.2.2.1. Pre-Clinical
        • 5.2.2.2. Phase I
        • 5.2.2.3. Phase II
        • 5.2.2.4. Phase III
        • 5.2.2.5. Phase IV
      • 5.2.3. Global Pharmacovigilance Outsourcing Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
    • 5.3. Global Pharmacovigilance Outsourcing (Price)
  • 6. Pharmacovigilance Outsourcing: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2019)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Accenture plc (Ireland)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Clinquest Group B.V (Netherlands)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Cognizant (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Laboratory Corporation of America Holdings (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. IBM (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. ArisGlobal LLC (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. ITClinical (Portugal)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Foresight Group International AG (Switzerland)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Take Solutions Ltd. (India)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Parexel International (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Pharmacovigilance Outsourcing Sale, by Services, Service Providers , Clinical Trial Phase and Region (value and price ) (2020-2025)
    • 7.1. Introduction
    • 7.2. Global Pharmacovigilance Outsourcing (Value)
      • 7.2.1. Global Pharmacovigilance Outsourcing by: Services (Value)
        • 7.2.1.1. Pre-marketing Pharmacovigilance Services (Clinical Pharmacovigilance Services, Case-Processing Services, Safety Data Management Services, Medical Review) Post-marketing Pharmacovigilance Services (Pharmacovigilance Knowledge Process Outsourcing Services, IT Solutions, and Services)
      • 7.2.2. Global Pharmacovigilance Outsourcing by: Clinical Trial Phase (Value)
        • 7.2.2.1. Pre-Clinical
        • 7.2.2.2. Phase I
        • 7.2.2.3. Phase II
        • 7.2.2.4. Phase III
        • 7.2.2.5. Phase IV
      • 7.2.3. Global Pharmacovigilance Outsourcing Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
    • 7.3. Global Pharmacovigilance Outsourcing (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Pharmacovigilance Outsourcing: by Services(USD Million)
  • Table 2. Pharmacovigilance Outsourcing Pre-marketing Pharmacovigilance Services (Clinical Pharmacovigilance Services, Case-Processing Services, Safety Data Management Services, Medical Review) Post-marketing Pharmacovigilance Services (Pharmacovigilance Knowledge Process Outsourcing Services, IT Solutions, and Services) , by Region USD Million (2014-2019)
  • Table 3. Pharmacovigilance Outsourcing: by Clinical Trial Phase(USD Million)
  • Table 4. Pharmacovigilance Outsourcing Pre-Clinical , by Region USD Million (2014-2019)
  • Table 5. Pharmacovigilance Outsourcing Phase I , by Region USD Million (2014-2019)
  • Table 6. Pharmacovigilance Outsourcing Phase II , by Region USD Million (2014-2019)
  • Table 7. Pharmacovigilance Outsourcing Phase III , by Region USD Million (2014-2019)
  • Table 8. Pharmacovigilance Outsourcing Phase IV , by Region USD Million (2014-2019)
  • Table 9. South America Pharmacovigilance Outsourcing, by Country USD Million (2014-2019)
  • Table 10. South America Pharmacovigilance Outsourcing, by Services USD Million (2014-2019)
  • Table 11. South America Pharmacovigilance Outsourcing, by Service Providers USD Million (2014-2019)
  • Table 12. South America Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2014-2019)
  • Table 13. Brazil Pharmacovigilance Outsourcing, by Services USD Million (2014-2019)
  • Table 14. Brazil Pharmacovigilance Outsourcing, by Service Providers USD Million (2014-2019)
  • Table 15. Brazil Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2014-2019)
  • Table 16. Argentina Pharmacovigilance Outsourcing, by Services USD Million (2014-2019)
  • Table 17. Argentina Pharmacovigilance Outsourcing, by Service Providers USD Million (2014-2019)
  • Table 18. Argentina Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2014-2019)
  • Table 19. Rest of South America Pharmacovigilance Outsourcing, by Services USD Million (2014-2019)
  • Table 20. Rest of South America Pharmacovigilance Outsourcing, by Service Providers USD Million (2014-2019)
  • Table 21. Rest of South America Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2014-2019)
  • Table 22. Asia Pacific Pharmacovigilance Outsourcing, by Country USD Million (2014-2019)
  • Table 23. Asia Pacific Pharmacovigilance Outsourcing, by Services USD Million (2014-2019)
  • Table 24. Asia Pacific Pharmacovigilance Outsourcing, by Service Providers USD Million (2014-2019)
  • Table 25. Asia Pacific Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2014-2019)
  • Table 26. China Pharmacovigilance Outsourcing, by Services USD Million (2014-2019)
  • Table 27. China Pharmacovigilance Outsourcing, by Service Providers USD Million (2014-2019)
  • Table 28. China Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2014-2019)
  • Table 29. Japan Pharmacovigilance Outsourcing, by Services USD Million (2014-2019)
  • Table 30. Japan Pharmacovigilance Outsourcing, by Service Providers USD Million (2014-2019)
  • Table 31. Japan Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2014-2019)
  • Table 32. India Pharmacovigilance Outsourcing, by Services USD Million (2014-2019)
  • Table 33. India Pharmacovigilance Outsourcing, by Service Providers USD Million (2014-2019)
  • Table 34. India Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2014-2019)
  • Table 35. South Korea Pharmacovigilance Outsourcing, by Services USD Million (2014-2019)
  • Table 36. South Korea Pharmacovigilance Outsourcing, by Service Providers USD Million (2014-2019)
  • Table 37. South Korea Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2014-2019)
  • Table 38. Taiwan Pharmacovigilance Outsourcing, by Services USD Million (2014-2019)
  • Table 39. Taiwan Pharmacovigilance Outsourcing, by Service Providers USD Million (2014-2019)
  • Table 40. Taiwan Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2014-2019)
  • Table 41. Australia Pharmacovigilance Outsourcing, by Services USD Million (2014-2019)
  • Table 42. Australia Pharmacovigilance Outsourcing, by Service Providers USD Million (2014-2019)
  • Table 43. Australia Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2014-2019)
  • Table 44. Rest of Asia-Pacific Pharmacovigilance Outsourcing, by Services USD Million (2014-2019)
  • Table 45. Rest of Asia-Pacific Pharmacovigilance Outsourcing, by Service Providers USD Million (2014-2019)
  • Table 46. Rest of Asia-Pacific Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2014-2019)
  • Table 47. Europe Pharmacovigilance Outsourcing, by Country USD Million (2014-2019)
  • Table 48. Europe Pharmacovigilance Outsourcing, by Services USD Million (2014-2019)
  • Table 49. Europe Pharmacovigilance Outsourcing, by Service Providers USD Million (2014-2019)
  • Table 50. Europe Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2014-2019)
  • Table 51. Germany Pharmacovigilance Outsourcing, by Services USD Million (2014-2019)
  • Table 52. Germany Pharmacovigilance Outsourcing, by Service Providers USD Million (2014-2019)
  • Table 53. Germany Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2014-2019)
  • Table 54. France Pharmacovigilance Outsourcing, by Services USD Million (2014-2019)
  • Table 55. France Pharmacovigilance Outsourcing, by Service Providers USD Million (2014-2019)
  • Table 56. France Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2014-2019)
  • Table 57. Italy Pharmacovigilance Outsourcing, by Services USD Million (2014-2019)
  • Table 58. Italy Pharmacovigilance Outsourcing, by Service Providers USD Million (2014-2019)
  • Table 59. Italy Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2014-2019)
  • Table 60. United Kingdom Pharmacovigilance Outsourcing, by Services USD Million (2014-2019)
  • Table 61. United Kingdom Pharmacovigilance Outsourcing, by Service Providers USD Million (2014-2019)
  • Table 62. United Kingdom Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2014-2019)
  • Table 63. Netherlands Pharmacovigilance Outsourcing, by Services USD Million (2014-2019)
  • Table 64. Netherlands Pharmacovigilance Outsourcing, by Service Providers USD Million (2014-2019)
  • Table 65. Netherlands Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2014-2019)
  • Table 66. Rest of Europe Pharmacovigilance Outsourcing, by Services USD Million (2014-2019)
  • Table 67. Rest of Europe Pharmacovigilance Outsourcing, by Service Providers USD Million (2014-2019)
  • Table 68. Rest of Europe Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2014-2019)
  • Table 69. MEA Pharmacovigilance Outsourcing, by Country USD Million (2014-2019)
  • Table 70. MEA Pharmacovigilance Outsourcing, by Services USD Million (2014-2019)
  • Table 71. MEA Pharmacovigilance Outsourcing, by Service Providers USD Million (2014-2019)
  • Table 72. MEA Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2014-2019)
  • Table 73. Middle East Pharmacovigilance Outsourcing, by Services USD Million (2014-2019)
  • Table 74. Middle East Pharmacovigilance Outsourcing, by Service Providers USD Million (2014-2019)
  • Table 75. Middle East Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2014-2019)
  • Table 76. Africa Pharmacovigilance Outsourcing, by Services USD Million (2014-2019)
  • Table 77. Africa Pharmacovigilance Outsourcing, by Service Providers USD Million (2014-2019)
  • Table 78. Africa Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2014-2019)
  • Table 79. North America Pharmacovigilance Outsourcing, by Country USD Million (2014-2019)
  • Table 80. North America Pharmacovigilance Outsourcing, by Services USD Million (2014-2019)
  • Table 81. North America Pharmacovigilance Outsourcing, by Service Providers USD Million (2014-2019)
  • Table 82. North America Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2014-2019)
  • Table 83. United States Pharmacovigilance Outsourcing, by Services USD Million (2014-2019)
  • Table 84. United States Pharmacovigilance Outsourcing, by Service Providers USD Million (2014-2019)
  • Table 85. United States Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2014-2019)
  • Table 86. Canada Pharmacovigilance Outsourcing, by Services USD Million (2014-2019)
  • Table 87. Canada Pharmacovigilance Outsourcing, by Service Providers USD Million (2014-2019)
  • Table 88. Canada Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2014-2019)
  • Table 89. Mexico Pharmacovigilance Outsourcing, by Services USD Million (2014-2019)
  • Table 90. Mexico Pharmacovigilance Outsourcing, by Service Providers USD Million (2014-2019)
  • Table 91. Mexico Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2014-2019)
  • Table 92. Company Basic Information, Sales Area and Its Competitors
  • Table 93. Company Basic Information, Sales Area and Its Competitors
  • Table 94. Company Basic Information, Sales Area and Its Competitors
  • Table 95. Company Basic Information, Sales Area and Its Competitors
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Pharmacovigilance Outsourcing: by Services(USD Million)
  • Table 103. Pharmacovigilance Outsourcing Pre-marketing Pharmacovigilance Services (Clinical Pharmacovigilance Services, Case-Processing Services, Safety Data Management Services, Medical Review) Post-marketing Pharmacovigilance Services (Pharmacovigilance Knowledge Process Outsourcing Services, IT Solutions, and Services) , by Region USD Million (2020-2025)
  • Table 104. Pharmacovigilance Outsourcing: by Clinical Trial Phase(USD Million)
  • Table 105. Pharmacovigilance Outsourcing Pre-Clinical , by Region USD Million (2020-2025)
  • Table 106. Pharmacovigilance Outsourcing Phase I , by Region USD Million (2020-2025)
  • Table 107. Pharmacovigilance Outsourcing Phase II , by Region USD Million (2020-2025)
  • Table 108. Pharmacovigilance Outsourcing Phase III , by Region USD Million (2020-2025)
  • Table 109. Pharmacovigilance Outsourcing Phase IV , by Region USD Million (2020-2025)
  • Table 110. South America Pharmacovigilance Outsourcing, by Country USD Million (2020-2025)
  • Table 111. South America Pharmacovigilance Outsourcing, by Services USD Million (2020-2025)
  • Table 112. South America Pharmacovigilance Outsourcing, by Service Providers USD Million (2020-2025)
  • Table 113. South America Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2020-2025)
  • Table 114. Brazil Pharmacovigilance Outsourcing, by Services USD Million (2020-2025)
  • Table 115. Brazil Pharmacovigilance Outsourcing, by Service Providers USD Million (2020-2025)
  • Table 116. Brazil Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2020-2025)
  • Table 117. Argentina Pharmacovigilance Outsourcing, by Services USD Million (2020-2025)
  • Table 118. Argentina Pharmacovigilance Outsourcing, by Service Providers USD Million (2020-2025)
  • Table 119. Argentina Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2020-2025)
  • Table 120. Rest of South America Pharmacovigilance Outsourcing, by Services USD Million (2020-2025)
  • Table 121. Rest of South America Pharmacovigilance Outsourcing, by Service Providers USD Million (2020-2025)
  • Table 122. Rest of South America Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2020-2025)
  • Table 123. Asia Pacific Pharmacovigilance Outsourcing, by Country USD Million (2020-2025)
  • Table 124. Asia Pacific Pharmacovigilance Outsourcing, by Services USD Million (2020-2025)
  • Table 125. Asia Pacific Pharmacovigilance Outsourcing, by Service Providers USD Million (2020-2025)
  • Table 126. Asia Pacific Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2020-2025)
  • Table 127. China Pharmacovigilance Outsourcing, by Services USD Million (2020-2025)
  • Table 128. China Pharmacovigilance Outsourcing, by Service Providers USD Million (2020-2025)
  • Table 129. China Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2020-2025)
  • Table 130. Japan Pharmacovigilance Outsourcing, by Services USD Million (2020-2025)
  • Table 131. Japan Pharmacovigilance Outsourcing, by Service Providers USD Million (2020-2025)
  • Table 132. Japan Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2020-2025)
  • Table 133. India Pharmacovigilance Outsourcing, by Services USD Million (2020-2025)
  • Table 134. India Pharmacovigilance Outsourcing, by Service Providers USD Million (2020-2025)
  • Table 135. India Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2020-2025)
  • Table 136. South Korea Pharmacovigilance Outsourcing, by Services USD Million (2020-2025)
  • Table 137. South Korea Pharmacovigilance Outsourcing, by Service Providers USD Million (2020-2025)
  • Table 138. South Korea Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2020-2025)
  • Table 139. Taiwan Pharmacovigilance Outsourcing, by Services USD Million (2020-2025)
  • Table 140. Taiwan Pharmacovigilance Outsourcing, by Service Providers USD Million (2020-2025)
  • Table 141. Taiwan Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2020-2025)
  • Table 142. Australia Pharmacovigilance Outsourcing, by Services USD Million (2020-2025)
  • Table 143. Australia Pharmacovigilance Outsourcing, by Service Providers USD Million (2020-2025)
  • Table 144. Australia Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2020-2025)
  • Table 145. Rest of Asia-Pacific Pharmacovigilance Outsourcing, by Services USD Million (2020-2025)
  • Table 146. Rest of Asia-Pacific Pharmacovigilance Outsourcing, by Service Providers USD Million (2020-2025)
  • Table 147. Rest of Asia-Pacific Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2020-2025)
  • Table 148. Europe Pharmacovigilance Outsourcing, by Country USD Million (2020-2025)
  • Table 149. Europe Pharmacovigilance Outsourcing, by Services USD Million (2020-2025)
  • Table 150. Europe Pharmacovigilance Outsourcing, by Service Providers USD Million (2020-2025)
  • Table 151. Europe Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2020-2025)
  • Table 152. Germany Pharmacovigilance Outsourcing, by Services USD Million (2020-2025)
  • Table 153. Germany Pharmacovigilance Outsourcing, by Service Providers USD Million (2020-2025)
  • Table 154. Germany Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2020-2025)
  • Table 155. France Pharmacovigilance Outsourcing, by Services USD Million (2020-2025)
  • Table 156. France Pharmacovigilance Outsourcing, by Service Providers USD Million (2020-2025)
  • Table 157. France Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2020-2025)
  • Table 158. Italy Pharmacovigilance Outsourcing, by Services USD Million (2020-2025)
  • Table 159. Italy Pharmacovigilance Outsourcing, by Service Providers USD Million (2020-2025)
  • Table 160. Italy Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2020-2025)
  • Table 161. United Kingdom Pharmacovigilance Outsourcing, by Services USD Million (2020-2025)
  • Table 162. United Kingdom Pharmacovigilance Outsourcing, by Service Providers USD Million (2020-2025)
  • Table 163. United Kingdom Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2020-2025)
  • Table 164. Netherlands Pharmacovigilance Outsourcing, by Services USD Million (2020-2025)
  • Table 165. Netherlands Pharmacovigilance Outsourcing, by Service Providers USD Million (2020-2025)
  • Table 166. Netherlands Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2020-2025)
  • Table 167. Rest of Europe Pharmacovigilance Outsourcing, by Services USD Million (2020-2025)
  • Table 168. Rest of Europe Pharmacovigilance Outsourcing, by Service Providers USD Million (2020-2025)
  • Table 169. Rest of Europe Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2020-2025)
  • Table 170. MEA Pharmacovigilance Outsourcing, by Country USD Million (2020-2025)
  • Table 171. MEA Pharmacovigilance Outsourcing, by Services USD Million (2020-2025)
  • Table 172. MEA Pharmacovigilance Outsourcing, by Service Providers USD Million (2020-2025)
  • Table 173. MEA Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2020-2025)
  • Table 174. Middle East Pharmacovigilance Outsourcing, by Services USD Million (2020-2025)
  • Table 175. Middle East Pharmacovigilance Outsourcing, by Service Providers USD Million (2020-2025)
  • Table 176. Middle East Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2020-2025)
  • Table 177. Africa Pharmacovigilance Outsourcing, by Services USD Million (2020-2025)
  • Table 178. Africa Pharmacovigilance Outsourcing, by Service Providers USD Million (2020-2025)
  • Table 179. Africa Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2020-2025)
  • Table 180. North America Pharmacovigilance Outsourcing, by Country USD Million (2020-2025)
  • Table 181. North America Pharmacovigilance Outsourcing, by Services USD Million (2020-2025)
  • Table 182. North America Pharmacovigilance Outsourcing, by Service Providers USD Million (2020-2025)
  • Table 183. North America Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2020-2025)
  • Table 184. United States Pharmacovigilance Outsourcing, by Services USD Million (2020-2025)
  • Table 185. United States Pharmacovigilance Outsourcing, by Service Providers USD Million (2020-2025)
  • Table 186. United States Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2020-2025)
  • Table 187. Canada Pharmacovigilance Outsourcing, by Services USD Million (2020-2025)
  • Table 188. Canada Pharmacovigilance Outsourcing, by Service Providers USD Million (2020-2025)
  • Table 189. Canada Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2020-2025)
  • Table 190. Mexico Pharmacovigilance Outsourcing, by Services USD Million (2020-2025)
  • Table 191. Mexico Pharmacovigilance Outsourcing, by Service Providers USD Million (2020-2025)
  • Table 192. Mexico Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2020-2025)
  • Table 193. Research Programs/Design for This Report
  • Table 194. Key Data Information from Secondary Sources
  • Table 195. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Pharmacovigilance Outsourcing: by Services USD Million (2014-2019)
  • Figure 5. Global Pharmacovigilance Outsourcing: by Clinical Trial Phase USD Million (2014-2019)
  • Figure 6. South America Pharmacovigilance Outsourcing Share (%), by Country
  • Figure 7. Asia Pacific Pharmacovigilance Outsourcing Share (%), by Country
  • Figure 8. Europe Pharmacovigilance Outsourcing Share (%), by Country
  • Figure 9. MEA Pharmacovigilance Outsourcing Share (%), by Country
  • Figure 10. North America Pharmacovigilance Outsourcing Share (%), by Country
  • Figure 11. Global Pharmacovigilance Outsourcing share by Players 2019 (%)
  • Figure 12. Global Pharmacovigilance Outsourcing share by Players (Top 3) 2019(%)
  • Figure 13. Global Pharmacovigilance Outsourcing share by Players (Top 5) 2019(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Accenture plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 16. Accenture plc (Ireland) Revenue: by Geography 2019
  • Figure 17. Clinquest Group B.V (Netherlands) Revenue, Net Income and Gross profit
  • Figure 18. Clinquest Group B.V (Netherlands) Revenue: by Geography 2019
  • Figure 19. Cognizant (United States) Revenue, Net Income and Gross profit
  • Figure 20. Cognizant (United States) Revenue: by Geography 2019
  • Figure 21. Laboratory Corporation of America Holdings (United States) Revenue, Net Income and Gross profit
  • Figure 22. Laboratory Corporation of America Holdings (United States) Revenue: by Geography 2019
  • Figure 23. IBM (United States) Revenue, Net Income and Gross profit
  • Figure 24. IBM (United States) Revenue: by Geography 2019
  • Figure 25. ArisGlobal LLC (United States) Revenue, Net Income and Gross profit
  • Figure 26. ArisGlobal LLC (United States) Revenue: by Geography 2019
  • Figure 27. ITClinical (Portugal) Revenue, Net Income and Gross profit
  • Figure 28. ITClinical (Portugal) Revenue: by Geography 2019
  • Figure 29. Foresight Group International AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 30. Foresight Group International AG (Switzerland) Revenue: by Geography 2019
  • Figure 31. Take Solutions Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 32. Take Solutions Ltd. (India) Revenue: by Geography 2019
  • Figure 33. Parexel International (United States) Revenue, Net Income and Gross profit
  • Figure 34. Parexel International (United States) Revenue: by Geography 2019
  • Figure 35. Global Pharmacovigilance Outsourcing: by Services USD Million (2020-2025)
  • Figure 36. Global Pharmacovigilance Outsourcing: by Clinical Trial Phase USD Million (2020-2025)
  • Figure 37. South America Pharmacovigilance Outsourcing Share (%), by Country
  • Figure 38. Asia Pacific Pharmacovigilance Outsourcing Share (%), by Country
  • Figure 39. Europe Pharmacovigilance Outsourcing Share (%), by Country
  • Figure 40. MEA Pharmacovigilance Outsourcing Share (%), by Country
  • Figure 41. North America Pharmacovigilance Outsourcing Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Accenture plc (Ireland)
  • Clinquest Group B.V (Netherlands)
  • Cognizant (United States)
  • Laboratory Corporation of America Holdings (United States)
  • IBM (United States)
  • ArisGlobal LLC (United States)
  • ITClinical (Portugal)
  • Foresight Group International AG (Switzerland)
  • Take Solutions Ltd. (India)
  • Parexel International (United States)
Additional players considered in the study are as follows:
Bioclinica (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation